Wafik El-Deiry, MD, PhD, FACP

Articles by Wafik El-Deiry, MD, PhD, FACP

Wafik El-Deiry, MD, PhD, FACPColorectal Cancer | March 13, 2025
Dr. El-Deiry expands on reducing ALDH1 expression in HT29 cells, and the benefits of targeting ERK1/2 and STAT3 activation.
View More
Wafik El-Deiry, MD, PhD, FACPColorectal Cancer | March 13, 2025
Dr. Wafik El-Deiry of Brown University discusses his study on regorafenib with TAS-102 for colorectal cancer.